(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-5.52% $ 1.710
Live Chart Being Loaded With Signals
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need...
Stats | |
---|---|
Volumen de hoy | 80 121.00 |
Volumen promedio | 367 004 |
Capitalización de mercado | 60.29M |
EPS | $0 ( 2024-03-28 ) |
Próxima fecha de ganancias | ( $-0.170 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.50 |
ATR14 | $0.0230 (1.35%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Tom Penny | Sell | 0 | Common Stock |
2024-03-06 | Tom Penny | Sell | 45 000 | Employee Stock Option (right to buy) |
2024-03-06 | Tom Penny | Sell | 40 000 | Employee Stock Option (right to buy) |
2024-03-06 | Tom Penny | Sell | 60 000 | Employee Stock Option (right to buy) |
2024-03-06 | Tom Penny | Sell | 40 000 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
61.76 |
Last 97 transactions |
Buy: 3 858 069 | Sell: 577 250 |
Volumen Correlación
Equillium Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
GRNV | 0.919 |
EGRX | 0.917 |
AXTI | 0.917 |
VVOS | 0.915 |
FVE | 0.909 |
BCRX | 0.906 |
NVEE | 0.904 |
OTRK | 0.903 |
BFRI | 0.903 |
CNSP | 0.898 |
10 Correlaciones Más Negativas | |
---|---|
AMRB | -0.94 |
LSTR | -0.939 |
RMBS | -0.937 |
LSCC | -0.936 |
MCHP | -0.932 |
KE | -0.93 |
SNSR | -0.926 |
SMH | -0.923 |
SOXX | -0.918 |
GRID | -0.917 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Equillium Inc Correlación - Moneda/Commodity
Equillium Inc Finanzas
Annual | 2023 |
Ingresos: | $36.08M |
Beneficio Bruto: | $35.96M (99.65 %) |
EPS: | $-0.380 |
FY | 2023 |
Ingresos: | $36.08M |
Beneficio Bruto: | $35.96M (99.65 %) |
EPS: | $-0.380 |
FY | 2022 |
Ingresos: | $15.76M |
Beneficio Bruto: | $15.64M (99.25 %) |
EPS: | $-3.19 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.579 |
Financial Reports:
No articles found.
Equillium Inc
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico